Esperion Therapeutics Inc (ESPR)
Financing Cash Flow
$59.90M
TTM · Period ending: · USD
ESPR Financing Cash Flow
Latest reported$59.90Mperiod ending
Latest reported$59.90Mperiod ending
ESPR Cash from Financing ($2.78M → $59.90M)
Annual financing cash flow
High-resolution chart · PNG
ESPR financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 36,184,000 | |
| 86,484,000 | |
| 50,460,000 | |
| 32,606,000 | |
| 268,223,000 | |
| 201,725,000 | |
| 136,195,000 | |
| 10,694,000 | |
| 163,458,000 | |
| -1,559,000 | |
| 190,522,000 | |
| 97,120,000 | |
| 89,141,340 | |
| 15,750,687 | |
| 6,715,886 | |
| 1,441,000 | |
| 25,016,000 | |
| 84,118,000 | |
| 2,779,276 |